21
22
Rutten, Karlijn H G, Raymakers, Reinier A P, Hazenberg, Bouke P C, Nienhuis, Hans L A, Vellenga, Edo, Minnema, Monique C
Veröffentlicht in: Rutten , K H G , Raymakers , R A P , Hazenberg , B P C , Nienhuis , H L A , Vellenga , E & Minnema , M C 2018 , ' Haematological response and overall survival in two consecutive Dutch patient cohorts with AL amyloidosis diagnosed between 2008 and 2016 ' , Amyloid , vol. 25 , no. 4 , pp. 227-233 . https://doi.org/10.1080/13506129.2018.1536043;
2018
Veröffentlicht in: Rutten , K H G , Raymakers , R A P , Hazenberg , B P C , Nienhuis , H L A , Vellenga , E & Minnema , M C 2018 , ' Haematological response and overall survival in two consecutive Dutch patient cohorts with AL amyloidosis diagnosed between 2008 and 2016 ' , Amyloid , vol. 25 , no. 4 , pp. 227-233 . https://doi.org/10.1080/13506129.2018.1536043;
2018
23
Minnema, Monique C., Hazenberg, Bouke, Croockewit, Alexandra J., Zweegman, Sonja, Kersten, Marie-Jose, Sonneveld, Pieter, Von dem Borne, Peter A., Bos, Gerard, de Waal, Esther, Vellenga, Edo, Lokhorst, Henk M.
Veröffentlicht in: Minnema , M C , Hazenberg , B , Croockewit , A J , Zweegman , S , Kersten , M-J , Sonneveld , P , Von dem Borne , P A , Bos , G , de Waal , E , Vellenga , E & Lokhorst , H M 2013 , ' De behandeling van AL-amyloïdose in Nederland anno 2013: Adviezen van de HOVON-werkgroep Multipel Myeloom ' , Nederlands Tijdschrift voor Hematologie , vol. 10 , no. 5 , pp. 165-179 .;
2013
Veröffentlicht in: Minnema , M C , Hazenberg , B , Croockewit , A J , Zweegman , S , Kersten , M-J , Sonneveld , P , Von dem Borne , P A , Bos , G , de Waal , E , Vellenga , E & Lokhorst , H M 2013 , ' De behandeling van AL-amyloïdose in Nederland anno 2013: Adviezen van de HOVON-werkgroep Multipel Myeloom ' , Nederlands Tijdschrift voor Hematologie , vol. 10 , no. 5 , pp. 165-179 .;
2013
24
de Waal, Esther G. M., Leene, Marnix, Veeger, Nic, Vos, Hanneke J., Ong, Francisca, Smit, Wilma G. J. M., Hovenga, Sjoerd, Hoogendoorn, Mels, Hogenes, Marieke, Beijert, Max, Diepstra, Arjan, Vellenga, Edo
Veröffentlicht in: de Waal , E G M , Leene , M , Veeger , N , Vos , H J , Ong , F , Smit , W G J M , Hovenga , S , Hoogendoorn , M , Hogenes , M , Beijert , M , Diepstra , A & Vellenga , E 2016 , ' Progression of a solitary plasmacytoma to multiple myeloma. A population-based registry of the northern Netherlands ' , British Journal of Haematology , vol. 175 , no. 4 , pp. 661-667 . https://doi.org/10.1111/bjh.14291;
2016
Veröffentlicht in: de Waal , E G M , Leene , M , Veeger , N , Vos , H J , Ong , F , Smit , W G J M , Hovenga , S , Hoogendoorn , M , Hogenes , M , Beijert , M , Diepstra , A & Vellenga , E 2016 , ' Progression of a solitary plasmacytoma to multiple myeloma. A population-based registry of the northern Netherlands ' , British Journal of Haematology , vol. 175 , no. 4 , pp. 661-667 . https://doi.org/10.1111/bjh.14291;
2016
25
de Waal, Esther G. M., Leene, Marnix, Veeger, Nic, Vos, Hanneke J., Ong, Francisca, Smit, Wilma G. J. M., Hovenga, Sjoerd, Hoogendoorn, Mels, Hogenes, Marieke, Beijert, Max, Diepstra, Arjan, Vellenga, Edo
Veröffentlicht in: British Journal of Haematology ; volume 175, issue 4, page 661-667 ; ISSN 0007-1048 1365-2141;
2016
Veröffentlicht in: British Journal of Haematology ; volume 175, issue 4, page 661-667 ; ISSN 0007-1048 1365-2141;
2016
26
Breems, Dimitri A., Boogaerts, Marc A., Dekker, Adriaan W., Van Putten, Wim L. J., Sonneveld, Pieter, Huijgens, Peter C., Van der Lelie, Johannes, Vellenga, Edo, Gratwohl, Alois, Verhoef, Gregor E. G., Verdonck, Leo F., Löwenberg, Bob
Veröffentlicht in: British Journal of Haematology ; volume 128, issue 1, page 59-65 ; ISSN 0007-1048 1365-2141;
2004
Veröffentlicht in: British Journal of Haematology ; volume 128, issue 1, page 59-65 ; ISSN 0007-1048 1365-2141;
2004
27
Pieter Sonneveld, Bronno van der Holt, Christine M. Segeren, Edo Vellenga, Alexandra J. Croockewit, Gregor E.G. Verhoef, Jan J. Cornelissen, Martijn R. Schaafsma, Marinus H.J. van Oers, Pierre W. Wijermans, Petra H.M. Westveer, Henk M. Lokhorst
Veröffentlicht in: Haematologica, Vol 92, Iss 7 (2007);
2007
Veröffentlicht in: Haematologica, Vol 92, Iss 7 (2007);
2007
28
Hazenberg, Bouke P. C., Croockewit, Alexandra, van der Holt, Bronno, Zweegman, Sonja, Bos, Gerard M. J., Delforge, Michel, Raymakers, Reinier A. P., Sonneveld, Pieter, Vellenga, Edo, Wijermans, Pierre W., von dem Borne, Peter A., van Oers, Marinus H., de Weerdt, Okke, Spoelstra, Fokje M., Lokhorst, Henk M.
Veröffentlicht in: Hazenberg , B P C , Croockewit , A , van der Holt , B , Zweegman , S , Bos , G M J , Delforge , M , Raymakers , R A P , Sonneveld , P , Vellenga , E , Wijermans , P W , von dem Borne , P A , van Oers , M H , de Weerdt , O , Spoelstra , F M , Lokhorst , H M & Dutch-Belgian Cooperative Trial Gr 2015 , ' Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine, doxorubicin, dexamethasone induction in amyloid light chain amyloidosis of the prospective phase II HOVON-41 study by the Dutch-Belgian Co-operative Trial Group for Hematology Oncology ' , Haematologica , vol. 100 , no. 5 , pp. 677-682 . https://doi.org/10.3324//haematol.2014.119198;
2015
Veröffentlicht in: Hazenberg , B P C , Croockewit , A , van der Holt , B , Zweegman , S , Bos , G M J , Delforge , M , Raymakers , R A P , Sonneveld , P , Vellenga , E , Wijermans , P W , von dem Borne , P A , van Oers , M H , de Weerdt , O , Spoelstra , F M , Lokhorst , H M & Dutch-Belgian Cooperative Trial Gr 2015 , ' Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine, doxorubicin, dexamethasone induction in amyloid light chain amyloidosis of the prospective phase II HOVON-41 study by the Dutch-Belgian Co-operative Trial Group for Hematology Oncology ' , Haematologica , vol. 100 , no. 5 , pp. 677-682 . https://doi.org/10.3324//haematol.2014.119198;
2015
29
Cruijsen, M, van der Velden, W J F M, de Haan, A F J, Klein, S K, Hoogendoorn, M, Tromp, Y, de Valk, B, van Rees, B, de Boer, F, van der Spek, E, Pruijt, J, Verdonck, L F, Vellenga, E, Blijlevens, N, van de Loosdrecht, A A, Huls, G
Veröffentlicht in: Cruijsen , M , van der Velden , W J F M , de Haan , A F J , Klein , S K , Hoogendoorn , M , Tromp , Y , de Valk , B , van Rees , B , de Boer , F , van der Spek , E , Pruijt , J , Verdonck , L F , Vellenga , E , Blijlevens , N , van de Loosdrecht , A A & Huls , G 2020 , ' Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands : the OCEAN study ' , Leukemia & Lymphoma , vol. 61 , no. 11 , pp. 2752-2755 . https://doi.org/10.1080/10428194.2020.1775217;
2020
Veröffentlicht in: Cruijsen , M , van der Velden , W J F M , de Haan , A F J , Klein , S K , Hoogendoorn , M , Tromp , Y , de Valk , B , van Rees , B , de Boer , F , van der Spek , E , Pruijt , J , Verdonck , L F , Vellenga , E , Blijlevens , N , van de Loosdrecht , A A & Huls , G 2020 , ' Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands : the OCEAN study ' , Leukemia & Lymphoma , vol. 61 , no. 11 , pp. 2752-2755 . https://doi.org/10.1080/10428194.2020.1775217;
2020
30
Ossenkoppele, Gert Jan, Stussi, Georg, Maertens, Johan, van Montfort, Kees, Biemond, Bart J., Breems, Dimitri, Ferrant, August, Graux, Carlos, de Greef, Georgine E., Halkes, C. J. M., Hoogendoorn, Mels, Hollestein, Rene M., Jongen-Lavrencic, Mojca, Levin, Mark-David, van de Loosdrecht, Arjan A., Kooij, Marinus van Marwijk, van Norden, Yvette, Pabst, Thomas, Schouten, Harry C., Vellenga, Edo, Verhoef, Gregor E. G., de Weerdt, Okke, Wijermans, Pierre, Passweg, Jakob R., Lowenberg, Bob
Veröffentlicht in: Ossenkoppele , G J , Stussi , G , Maertens , J , van Montfort , K , Biemond , B J , Breems , D , Ferrant , A , Graux , C , de Greef , G E , Halkes , C J M , Hoogendoorn , M , Hollestein , R M , Jongen-Lavrencic , M , Levin , M-D , van de Loosdrecht , A A , Kooij , M V M , van Norden , Y , Pabst , T , Schouten , H C , Vellenga , E , Verhoef , G E G , de Weerdt , O , Wijermans , P , Passweg , J R & Lowenberg , B 2012 , ' Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK) ' , Blood , vol. 120 , no. 24 , pp. 4706-4711 . https://doi.org/10.1182/blood-2012-04-420596;
2012
Veröffentlicht in: Ossenkoppele , G J , Stussi , G , Maertens , J , van Montfort , K , Biemond , B J , Breems , D , Ferrant , A , Graux , C , de Greef , G E , Halkes , C J M , Hoogendoorn , M , Hollestein , R M , Jongen-Lavrencic , M , Levin , M-D , van de Loosdrecht , A A , Kooij , M V M , van Norden , Y , Pabst , T , Schouten , H C , Vellenga , E , Verhoef , G E G , de Weerdt , O , Wijermans , P , Passweg , J R & Lowenberg , B 2012 , ' Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK) ' , Blood , vol. 120 , no. 24 , pp. 4706-4711 . https://doi.org/10.1182/blood-2012-04-420596;
2012